GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Akorn, Inc. (AKRX) [hlAlert]

Rating:
Outperform
AKRX
up 522.50 %

Akorn, Inc. (AKRX) rated Outperform by Friedman Billings

Posted on: Friday,  Feb 8, 2008  8:25 AM ET by Friedman Billings

Friedman Billings rated Outperform Akorn, Inc. (NASDAQ: AKRX) on 02/08/2008, when the stock price was $6.62. Since
then, Akorn, Inc. has gained 522.51% as of 01/22/2016's recent price of $41.21.
If you would have followed this Friedman Billings's recommendation on AKRX, you would have gained 522.5% of your investment in 2905 days.

Akorn, Inc. is engaged in manufacturing and marketing diagnostic and therapeutic pharmaceuticals in specialty areas, such as ophthalmology, rheumatology, anesthesia and antidotes, among others. In addition, the Company markets and distributes vaccines purchased from outside sources. Its customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations and other pharmaceutical companies. It has a wholly owned subsidiary named Akorn (New Jersey), Inc., which operates in Somerset, New Jersey and is involved in manufacturing, product development, and administrative activities related to its ophthalmic and hospital drugs & injectables segments. The Company operates in four segments: ophthalmic, hospital drugs & injectables, biologics & vaccines and contract services.

FBR Capital Markets is a full service investment banking, institutional sales, trading and research and asset management firm with a customer-focused and innovative approach to meeting its clients needs. It focuses its banking, advisory, trading and research efforts on seven broad industry sectors including consumer, diversified industrials, energy & natural resources, financial institutions, insurance, real estate and technology, media & telecom. With our headquarters in the Washington, D.C. metropolitan area, our Economic and Washington Policy Analysis groups offer clients a comprehensive overview of national economic trends along with a unique perspective on the impact that legislation and regulation will have on industry sectors and individual companies
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/8/2008 8:25 AM Buy
None
6.62
as of 12/24/2008
1 Week down  -14.70 %
1 Month down  -34.09 %
3 Months down  -58.57 %
1 YTD down  -62.17 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy